Table II:
GDT use by comorbidity. Number and percent of patients receiving the components of GDT for each comorbidity.
| GDT use by comorbidity | Eligible | On Treatment | % On Treatment |
|---|---|---|---|
| CAD | |||
| Antiplatelet agent | 993 | 745 | 75.0% |
| Beta blocker | 6990 | 5137 | 73.5% |
| ACEi/ARB | 3447 | 2196 | 63.7% |
| Statin | 6990 | 5109 | 73.1% |
| Taking all eligible therapies | 6990 | 3145 | 45.0% |
| Diabetes mellitus | |||
| ACE/ARB | 6294 | 3818 | 60.7% |
| Statin | 6294 | 4150 | 65.9% |
| Taking all eligible therapies | 6294 | 2711 | 43.1% |
| Heart failure | |||
| Beta blocker | 6001 | 4584 | 76.4% |
| ACEi/ARB | 3509 | 2288 | 65.2% |
| Aldosterone antagonist | 1142 | 187 | 16.4% |
| ICD | 1119 | 507 | 45.3% |
| Taking all eligible therapies | 6001 | 2822 | 47.0% |
| Hyperlipidemia | |||
| Statin | 9282 | 7020 | 75.6% |
| Hypertension | |||
| Antihypertensive | 18474 | 9991 | 54.1% |
| PVD | |||
| Statin | 2358 | 1587 | 67.3% |
| Obstructive sleep apnea | |||
| CPAP | 4045 | 2333 | 57.7% |
ACEi = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta blocker; CAD = coronary artery disease; HF = heart failure; CPAP = continuous positive airway pressure; ICD = implantable cardioverter defibrillator; OSA = obstructive sleep apnea; PVD = peripheral vascular disease.